References
- Balamurugan V, Kumar RM, Suryanarayana VV: Past and present vaccine development strategies for the control of foot-and-mouth disease. Acta Virol 48;201-214, 2004
- Knowles NJ, Samuel AR, Davies PR, Midgley RJ, Valarcher JF: Pandemic strain of foot-and-mouth disease virus serotype O. Emerg Infect Dis 11;1887-1893, 2005 https://doi.org/10.3201/eid1112.050908
- Patil PK, Suryanarayana V, Bist P, Bayry J, Natarajan C: Integrity of GH-loop of foot-and-mouth disease virus during virus inactivation: detection by epitope specific antibodies. Vaccine 20;1163-1168, 2002 https://doi.org/10.1016/S0264-410X(01)00431-5
- Collen T, Dimarchi R, Doel TR: A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol 146;749-755, 1991
- Wang JH, Liang CM, Peng JM, Shieh JJ, Jong MH, Lin YL, Sieber M, Liang SM: Induction of immunity in swine by purified recombinant VP1 of foot-and-mouth disease virus: Vaccine 21;3721-3729, 2003 https://doi.org/10.1016/S0264-410X(03)00363-3
- Sanz-Parra A, Sobrino F, Ley V: Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression. J Gen Virol 79:433-436, 1998 https://doi.org/10.1099/0022-1317-79-3-433
- Yang NS, Wang JH, Lin KF, Wang CY, Kim SA, Yang YL, Jong MH, Kuo TY, Lai SS, Cheng RH, Chan MT, Liang SM: Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus. J Gene Med 7;708-717, 2005 https://doi.org/10.1002/jgm.723
- Borrego B, Fernandez-Pacheco P, Ganges L, Domenech N, Fernandez-Borges N, Sobrino F, Rodriguez F: DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses. Vaccine 24;3889-3899, 2006 https://doi.org/10.1016/j.vaccine.2006.02.028
- Collen T, Baron J, Childerstone A, Corteyn A, Doel TR, Flint M, Garcia-Valcarcel M, Parkhouse RM, Ryan MD: Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen. Virus Res 56;125-133, 1998 https://doi.org/10.1016/S0168-1702(98)00035-5
- Cedillo-Barron L, Foster-Cuevas M, Cook A, Gutierrez- Castaneda B, Kollnberger S, Lefevre F, Parkhouse RM: Immunogenicity of plasmids encoding T and B cell epitopes of foot-and-mouth disease virus (FMDV) in swine. Vaccine 21;4261-4269, 2003 https://doi.org/10.1016/S0264-410X(03)00453-5
- Eriksson E, Yao F, Svensjo T, Winkler T, Slama J, Macklin MD, Andree C, McGregor M, Hinshaw V, Swain WF: In vivo gene transfer to skin and wound by microseeding. J Surg Res 78;85-91, 1998 https://doi.org/10.1006/jsre.1998.5325
- Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G, Gromkowski SH, Singh M, Lew D, Yankauckas MA, et al.: Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci U S A 91;9519-9523, 1994 https://doi.org/10.1073/pnas.91.20.9519
- Bautista EM, Ferman GS, Gregg D, Brum MC, Grubman MJ, Golde WT: Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus. J Virol 79;4838-4847, 2005 https://doi.org/10.1128/JVI.79.8.4838-4847.2005
- Yang JS, Kim JJ, Hwang D, Choo AY, Dang K, Maguire H, Kudchodkar S, Ramanathan MP, Weiner DB: Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999). J Infect Dis 184;809-816, 2001 https://doi.org/10.1086/323395
- Kim SA, Liang CM, Cheng IC, Cheng YC, Chiao MT, Tseng CJ, Lee F, Jong MH, Tao MH, Yang NS, Liang SM: DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity. J Gene Med 8;1182-1191, 2006 https://doi.org/10.1002/jgm.941
- Park JH, Kim SJ, Oem JK, Lee KN, Kim YJ, Kye SJ, Park JY, Joo YS: Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes. J Vet ScI 7;257-262, 2006 https://doi.org/10.4142/jvs.2006.7.3.257
- Cedillo-Barron L, Foster-Cuevas M, Belsham GJ, Lefevre F, Parkhouse RM: Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J Gen Virol 82;1713-1724, 2001 https://doi.org/10.1099/0022-1317-82-7-1713
- Zhang Q, Zhu MW, Yang YQ, Shao M, Zhang ZY, Lan HY, Yan WY, Wu JJ, Zheng ZX: A recombinant fusion protein and DNA vaccines against foot-and-mouth disease virus type Asia 1 infection in guinea pigs. Acta Virol 47;237-243, 2003
- van Lierop MJ, Wagenaar JP, van Noort JM, Hensen EJ: Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J Virol 69;4511-4514, 1995
- Chinsangaram J, Beard C, Mason PW, Zellner MK, Ward G, Grubman MJ: Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J Virol 72;4454-4457, 1998
Cited by
- Foot and mouth disease virus polyepitope protein produced in bacteria and plants induces protective immunity in guinea pigs vol.76, pp.3, 2009, https://doi.org/10.1134/s0006297911030072
- Strategies for Combating and Eradicating Important Infectious Diseases of Animals with Particular Reference to India: Present and Future Perspectives vol.9, pp.2, 2009, https://doi.org/10.3923/ajava.2014.77.106
- Foot-and-mouth disease: overview of motives of disease spread and efficacy of available vaccines vol.57, pp.1, 2009, https://doi.org/10.1186/s40781-015-0042-8
- In silico site-directed mutagenesis of neutralizing mAb 4C4 and analysis of its interaction with G-H loop of VP1 to explore its therapeutic applications against FMD vol.37, pp.10, 2009, https://doi.org/10.1080/07391102.2018.1494631
- Better Understanding of Important Aspects Associated with Vaccines Development for Controlling Viral Diseases in Animals vol.15, pp.3, 2009, https://doi.org/10.3923/ijds.2020.114.122